Anticoagulation therapy is essential after cardiac valve surgery. However, spontaneous bleeding remains a major concern during anticoagulation therapy. Spontaneous gallbladder (GB) hemorrhage (hemobilia) is a rare occurrence during standard anticoagulation therapy. This report presents a case of GB hemorrhage that occurred shortly after initiating oral anticoagulant therapy in a patient who had undergone mitral valve replacement surgery.
with atrial fibrillation and severe mitral regurgitation. Coronary angiography revealed a coronary artery fistula from the proximal left anterior descending coronary artery to the main pulmonary artery. The patient underwent mitral valve replacement, the Cox-Maze III procedure, and external ligation of the coronary fistula. On the first postoperative day, the patient began taking aspirin and clopidogrel. On the second postoperative day, he received 2 mg of warfarin as a starting dose.
He was also injected with enoxaparin subcutaneously together with warfarin until his prothrombin time (PT)/international normalized ratio (INR) remained above 1.5 for a prolonged period. He had mild hyperbilirubinemia (total bilirubin level, 2.66 mg/dL) in the immediate postoperative period, his total bilirubin level gradually decreased, reaching a normal level on the fifth day after the operation.
On the eighth day after the operation, the patient complained of postprandial epigastric pain. His physical examination was significant for cold sweating with a body temperature of 37. The common bile duct is dilated and a filling defect is present (arrow) when contrast media is injected through the percutaneous transhepatic gallbladder drainage tube, suggesting a blood clot in the bile duct.
anticoagulant medication was stopped, parenteral nutrition was initiated, and the patient was transferred to the hepatobiliary department in order to perform percutaneous transhepatic gallbladder drainage (PTGBD). Endoscopic retrograde cholangiography was performed and a drain was inserted three days after PTGBD. The endoscopy findings included hematoma and acute cholangitis (Fig. 2) . After ten days of PTGBD and monitoring the color of the drainage, the drain output turned clear. On the same day, a repeat cholangiogram showed no evidence of ongoing bleeding, and most of the hematoma had resolved. During these ten days, the patient underwent anticoagulation with enoxaparin (200 mg of Clexane twice a day).
Upon the resolution of hemobilia, he restarted warfarin and was discharged after the PTGBD was removed on postoperative day 28.
DISCUSSION
Hemobilia is a hemorrhage into the biliary tract [1] . The term hemobilia was coined by Sandblom in 1948 to describe hemorrhage into the biliary tract as a result of a communication or fistula between the biliary tract and the arteriovenous circulation [2] . Hemobilia is not a common complication, but urgent management is required to avoid complications such as GB perforation. Several factors may cause GB hemorrhages, including biliary obstruction, acute and chronic cholecystitis, neoplasm, coagulopathy, and iatrogenic injury [3] .
Recently, the most common cause of hemobilia has been reported to be trauma, with iatrogenic causes being the most important [4] . The clinical manifestations of hemobilia, known as Quincke's triad, consist of right upper quadrant abdominal pain, jaundice, and upper gastrointestinal tract hemorrhage [5] . The etiology of the hemorrhage is thought to involve chronic inflammation of the gallbladder lumen.
Pathologic findings can include transmural inflammation of the GB wall, which can lead to infarction and erosion of the mucosa, in turn causing hemorrhage into the gallbladder lumen [6] . While this patient was receiving anticoagulant therapy, bleeding from the lesion caused bile duct obstruction due to hemobilia. Computed tomography scans may assist in the diagnosis of hemobilia, which has a characteristic finding of high attenuation within the gallbladder lumen with a layered fluid level presenting as blood or sludge [7] .
Ultrasonography can be also a useful diagnostic tool, especially for patients with severe renal failure.
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Warfarin therapy increases the risk of major bleeding by 0.3%-0.5% per year [8] . Warfarin interferes with the hepatic synthesis of vitamin K-dependent clotting factors II, VII, IX, and X, resulting in their eventual depletion and prolongation of the clotting time, as measured by the PT and INR [9] .
Triple antithrombotic therapy is indicated for atrial fibrillation patients undergoing stent insertion who are at a high risk for stroke (CHADS2 risk score ＞1), but not for bleeding [10] .
Since this patient's CHADS2 risk score was 2 and he did not have an elevated risk of bleeding, we considered triple antith- 
